AMPHADASE 150 [USP'U]/mL
hyaluronidase · INJECTION · Amphastar Pharmaceuticals, Inc.
No Recall History
Plain English
AMPHADASE is a injection containing hyaluronidase at 150 [USP'U]/mL, taken subcutaneous. Manufactured by Amphastar Pharmaceuticals, Inc..
Key Facts
- Brand Name
- AMPHADASE
- Generic Name
- hyaluronidase
- NDC Code (Product)
0548-9090- Manufacturer
- Amphastar Pharmaceuticals, Inc.
- Strength
- 150 [USP'U]/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021665
- Drug Class
- Endoglycosidase [EPC]
- Marketing Start
- 10/26/2004
Recall History
No Recall HistoryFrequently Asked Questions
What is AMPHADASE used for?
AMPHADASE contains hyaluronidase. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is AMPHADASE a controlled substance?
AMPHADASE is not classified as a controlled substance by the DEA.
What is the generic name for AMPHADASE?
The generic name for AMPHADASE is hyaluronidase. There are 2 other brand versions of hyaluronidase.
What is the NDC code for AMPHADASE 150 [USP'U]/mL?
The NDC (National Drug Code) for AMPHADASE 150 [USP'U]/mL is 0548-9090, listed by Amphastar Pharmaceuticals, Inc..